DE69527802D1 - Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten - Google Patents

Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten

Info

Publication number
DE69527802D1
DE69527802D1 DE69527802T DE69527802T DE69527802D1 DE 69527802 D1 DE69527802 D1 DE 69527802D1 DE 69527802 T DE69527802 T DE 69527802T DE 69527802 T DE69527802 T DE 69527802T DE 69527802 D1 DE69527802 D1 DE 69527802D1
Authority
DE
Germany
Prior art keywords
substituted
derivatives
benzyl
rhodanin
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527802T
Other languages
English (en)
Other versions
DE69527802T2 (de
Inventor
Martin Hansen
Robert Harkness
Van Khau
John Martinelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69527802D1 publication Critical patent/DE69527802D1/de
Publication of DE69527802T2 publication Critical patent/DE69527802T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69527802T 1994-12-21 1995-12-14 Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten Expired - Fee Related DE69527802T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/361,281 US5563277A (en) 1994-12-21 1994-12-21 Process for preparing benzyl-substituted rhodanine derivatives
PCT/US1995/016372 WO1996019466A1 (en) 1994-12-21 1995-12-14 Process for preparing benzyl-substituted rhodanine derivatives

Publications (2)

Publication Number Publication Date
DE69527802D1 true DE69527802D1 (de) 2002-09-19
DE69527802T2 DE69527802T2 (de) 2003-04-10

Family

ID=23421401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527802T Expired - Fee Related DE69527802T2 (de) 1994-12-21 1995-12-14 Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten

Country Status (9)

Country Link
US (1) US5563277A (de)
EP (1) EP0799215B1 (de)
JP (1) JPH10511352A (de)
AT (1) ATE222245T1 (de)
AU (1) AU4520596A (de)
CA (1) CA2207901A1 (de)
DE (1) DE69527802T2 (de)
ES (1) ES2181809T3 (de)
WO (1) WO1996019466A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761657B1 (de) * 1995-09-07 2000-05-24 Eli Lilly And Company Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten
US6005142A (en) 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048159A3 (de) * 1980-09-17 1982-05-12 University Of Miami Carboxyalkyl-Peptide und Thioäther und Äther von Peptiden als antihypertensive Mittel
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
DE69027472T2 (de) * 1989-04-07 1996-12-05 Lilly Co Eli Arylsubstituierte Rhodaninderivate
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
ZA9010041B (en) * 1989-12-21 1992-08-26 Lilly Co Eli Compounds for treating inflammatory bowel disease
FI922867A (fi) * 1991-06-21 1992-12-22 Tanabe Seiyaku Co Dikarbonsyraderivat och foerfarande foer framstaellning av dem
GB9213934D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Chemical compounds
ES2121036T3 (es) * 1992-07-14 1998-11-16 Nippon Chemiphar Co Derivados de alquilenodiamina.
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
JPH06234630A (ja) * 1992-12-17 1994-08-23 Tanabe Seiyaku Co Ltd 中性メタロエンドペプチダーゼ阻害剤
US5476865A (en) * 1994-07-06 1995-12-19 Eli Lilly And Company Methods of inhibiting bone loss

Also Published As

Publication number Publication date
AU4520596A (en) 1996-07-10
US5563277A (en) 1996-10-08
DE69527802T2 (de) 2003-04-10
JPH10511352A (ja) 1998-11-04
EP0799215A4 (de) 1998-03-11
ES2181809T3 (es) 2003-03-01
CA2207901A1 (en) 1996-06-27
EP0799215B1 (de) 2002-08-14
ATE222245T1 (de) 2002-08-15
EP0799215A1 (de) 1997-10-08
WO1996019466A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
DE69624976D1 (de) Verfahren zur Herstellung von MOS-Leistungstransistoren
DE69615453T2 (de) Verfahren zur Herstellung von mikrokapselhaltigen Zusammensetzungen
DE59108655D1 (de) Verfahren zur Herstellung von Celluloseformkörpern
ATE169294T1 (de) Verbindungen zur behandlung von bauchentzündungen
DE69624825T2 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
DE69126477D1 (de) Verfahren zur Herstellung von Feldeffekttransistoren
DE69527802T2 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
DE69808771T2 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
DE59010896D1 (de) Verfahren zur Herstellung von 7-(3-Amino- sowie 3-Aminomethyl-1-pyrrolidinyl)-3-chinolon-carbonsäuren sowie -naphthyridoncarbonsäuren
ATE131488T1 (de) Neues verfahren zur herstellung von hydrocortison sowie zwischenprodukten dafür
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE68903570D1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
DE69500313D1 (de) Neues verfahren zur herstellung von clonidin-derivaten
DE59402632D1 (de) Verfahren zur Herstellung von 3beta-Aminocholansäurederivaten
ATE193284T1 (de) Verfahren zur herstellung von benzylsubstituierten rhodaninederivaten
ATE111093T1 (de) Verfahren zur herstellung von enantiomeren von 3- aminchromanderivaten.
DE69616801D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE59107514D1 (de) Verfahren zur Herstellung von Cyclopropannitrilderivaten
ATE24718T1 (de) Alkylcycloalkyl-imidazolylmethyl-ketone und verfahren zu ihrer herstellung.
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
DE50000755D1 (de) Verfahren zur herstellung von 4,4- dimethyl -3beta- hydroxypregna -8,14-dien-21- carbonsäureestern und zwischenprodukte im verfahren
ATA45890A (de) Verfahren zur herstellung von hartgelatinekapsel-zusammensetzungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee